Which are the causes of Polymyalgia Rheumatica?

Polymyalgia rheumatica is an inflammatory disorder with no single known cause, though it is widely believed to result from a combination of genetic susceptibility and environmental triggers. Current research indicates that Polymyalgia rheumatica develops through an immune-mediated mechanism where the body’s defense system mistakenly attacks the joints and surrounding tissues.

What causes Polymyalgia rheumatica?

The exact etiology of Polymyalgia rheumatica remains unknown, but it is classified as an autoimmune-mediated inflammatory condition. It is helpful to think of the immune system as a "security guard" that has become hyper-vigilant; in Polymyalgia rheumatica, this system begins to perceive healthy shoulder and hip tissues as foreign invaders, triggering chronic inflammation.

Are there genetic or environmental risk factors?

While Polymyalgia rheumatica is not considered a strictly hereditary disease, researchers have identified certain risk factors that increase the likelihood of developing the condition:

• Age: It is rarely seen in people under age 50, with the average age of onset being around 70 years old.


• Genetics: Certain human leukocyte antigen (HLA) gene markers, specifically HLA-DRB1 alleles, have been associated with an increased risk.


• Environment: Some studies suggest that seasonal patterns of onset or exposure to certain viral or bacterial infections may act as a "trigger" for genetically predisposed individuals.


• Ancestry: People of Northern European descent have a significantly higher incidence rate compared to other global populations.

How does the immune system influence the disease?

In Polymyalgia rheumatica, the inflammation is localized primarily in the synovial lining of the joints and the bursae. Researchers are currently investigating how cytokines—small proteins that act as messengers in the immune system—become dysregulated, leading to the characteristic pain and stiffness seen in Polymyalgia rheumatica. Distinguishing between a "cause" (the root initiator) and a "risk factor" (a contributing element) is a major focus of ongoing clinical studies to improve diagnostic precision.

Next steps

• Consult a rheumatologist for a formal evaluation of your symptoms and inflammatory markers.


• Connect with the 52 members of the Polymyalgia rheumatica community on DiseaseMaps.org to share experiences.


• Keep a symptom diary to track how your morning stiffness responds to prescribed treatments.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: Portal for rare diseases and orphan drugs


• American College of Rheumatology: Polymyalgia Rheumatica guidelines


• PubMed/NCBI: Clinical reviews on the pathophysiology of large-vessel vasculitis and PMR